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Objectives: To evaluate the effective dose and image quality of horizontal CBCT in
comparison with multislice spiral CT (MSCT) in scans of the head, cervical spine, ear and
dental arches.
Methods: A head and neck Alderson-Rando® phantom (The Phantom Laboratory, Salem,
NY) equipped with 74 thermoluminescence dosemeters was exposed according to 5 different
scans in CBCT and 4 different scans in MSCT. Spatial and contrast resolutions, in terms of
modulation transfer function and contrast-to-noise ratio (CNR), were measured to obtain
a quantitative assessment of image quality.
Results: The CBCT effective dose was 248, 249, 361, 565 and 688 mSv in the cervical spine,
head, ear, dental arches with small field of view and dental arches with medium field of view,
respectively. The MSCT effective dose was 3409, 1892, 660 and 812 mSv in the cervical spine,
head, ear and dental arches, respectively. The modulation transfer function was 0.895 vs
0.347, 0.895 vs 0.275, 0.875 vs 0.342 and 0.961 vs 0.352 for CBCT vs MSCT in the cervical
spine, head, ear and dental arches, respectively. Head and cervical spine MSCT showed
greater CNR than CBCT, whereas CNR of the ear and dental arches showed
comparable values.
Conclusions: CBCT was preferable to MSCT for the ear and dental arches volumetric
imaging due to its lower radiation dose and significantly higher spatial resolution. In the case
of cervical spine and head imaging, MSCT should be generally recommended if a high
contrast resolution is required, despite the greater radiation exposure.
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Introduction
In recent years, employment of diagnostic radiography
has increased progressively, and at the same time, the
cancer risk induced by multislice spiral CT (MSCT)
scans seems to have increased.1 CBCT is a relatively
new imaging technique that has recently emerged in the
field of radiodiagnostics. It utilizes a conic/pyramidal
X-ray beam which hits a two-dimensional detector
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(image intensifier or flat panel) during a lengthy single
rotation (5.4–40 s).2 The reduced presence of metal
artefacts and the high spatial resolution (0.075–0.4 mm
isotropic voxel) have made CBCT a technique widely
used not only in dentomaxillofacial radiology3 but also
for cervical spine and middle ear imaging.4
Many studies investigated head/dental CBCT effec-
tive dose and dosimetric differences between MSCT and
CBCT.5–9 They proved that the CBCT effective dose is
undoubtedly lower than the MSCT dose, regardless of
the broad variability in CBCT dose resulting from the
appliance and the protocol employed.
However, only few studies concerning the head and
neck area tried to establish a relationship between ef-
fective dose and quantitative measurement of image
quality.6,10–12 Moreover, there are only three works on
ear dose,10,13,14 and no article exists regarding spine dose.
The aim of this study was to evaluate the effective
dose and image quality of horizontal CBCT in com-
parison with MSCT in the scans of the head, cervical
spine, ear and dental arches (concurrently the upper and
lower jaws).
Methods and materials
Devices and protocols
Scans were carried out via SOMATOM® Sensation 64
MSCT (Siemens, Erlangen, Germany) and New-
Tom5G CBCT (QR srl, Verona, Italy). The latter was
equipped with a pulsed pyramidal X-ray beam (360° of
rotation), a very small focal spot (0.3 mm) and an
amorphous silicon flat-panel detector (203 25 cm). In
addition, it embedded the SafeBeam. This technology
features the use of intermittent bursts of radiation (ms)
and automatically adjusts the radiation dosage by
modifying the tube current (mA) according to pre-set
dose levels determined by the patient’s size as measured
on the scout images.
All technical/geometrical parameters were the same
as those used in the clinical practice (Table 1). Since
even small modifications in the size and position of field
of view (FOV) heavily influenced the effective dose, an
accurate positioning of FOV was mandatory (Figure 1).
In CBCT, the FOV of the head was the widest
available (183 16 cm). It was placed so that the soft
tissues of the nose and chin were completely included to
fulfil the clinician’s requirements for orthognathodontic
treatment/surgical planning; the cranial vertex and oc-
cipital bone were thus excluded. In MSCT, the FOV of
the head included the entire skull since scanning the
head for orthognathodontic purposes is not recom-
mended due to the high radiation dose.7,15 The FOV of
the cervical spine, ear and dental arches was kept as
similar as possible between both devices whilst still
trying to maintain the standard settings. CBCT of
dental arches was studied with two different FOVs:
small (83 8 cm) and medium (123 8 cm). It is
important to remind that an exact dosimetric match
between CBCT and MSCT is only achievable when the
FOV of CBCT completely includes the scanned object.
In MSCT, the diameter of the X-ray beam always
covers the entire object, therefore only the scan length is
relevant from a dosimetric point of view.
NewTom5G exposure parameters could not be al-
tered by the operator and were automatically set in re-
lation to the FOV, radiographic absorption and
available acquisition protocol. The two protocols cho-
sen—named standard-regular and high-resolution (hi-
res) enhanced by the producer—lasted 18 and 36 s, and
included 360 and 480 basis image frames, respectively.
The protocol was chosen accordingly to the diagnostic
application. The ear and dental arches were acquired
with smaller voxels and greater mA (hi-res-enhanced
protocol) than the head and cervical spine (standard-
regular protocol) to better depict fine anatomical
structures such as ossicular chain in ear study or neu-
rovascular canal in dental extractive/implant planning.
Both CBCT and MSCT scans were performed at nor-
mal dose settings, except for scans of the dental arches
with MSCT, which were conducted at significantly re-
duced dose settings by decreasing mAs value (low-dose
Dentascan).16
Phantom and experimental setup
An adult male Alderson-Rando® anthropomorphic
phantom (The Phantom Laboratory, Salem, NY) was
used. The phantom consisted of a real human skeleton
filled with tissue equivalent material according to The
International Commission on Radiation Units and
Measurements-44 specification, transected horizontally
into 2.5-cm-thick slices from the head vertex to the
groin. For the current study, only the upper 12 slices
(i.e. head and neck) were used. Each slice had cylindrical
drilled holes in default locations that were plugged with
two lithium fluoride (LiF:Mg,Ti) thermoluminescence
dosemeter (TLD-100 rods; Harshaw Chemical Com-
pany, Solon, OH) chips (3.23 3.23 0.5mm) to measure
radiation exposure. The holes used for the measurements
were chosen among those that more accurately repre-
sented the anatomical location of the organs of interest
(Table 2). The dosimetric response for each hole was
calculated as the arithmetic mean of the two thermolu-
minescence dosemeter (TLD) chip exposures. 37 ana-
tomical sites were considered for both CBCT and
MSCT, thereby 74 TLDs were used for each scan.
Consequently, a total of 370 and 296 dosemeters were
used in the 5 CBCT and 4 MSCT scans, respectively. The
TLD response was well above the background dose and
also showed low variability in each phantom hole. For
this reason, only one exposure was performed for each
technique and therefore no scan was repeated.
The phantom was always positioned with a headrest
as if it were a real patient, so that
– the occlusal plane was perpendicular to the pa-
tient table
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– the midheight/midsagittal plane was centred on the
horizontal/vertical positioning light beam
– the midsagittal plane was aligned with the midline of
the gantry.
Dosimetric method and effective dose calculation
Dosimetric evaluation17 was performed with TLDs. On
irradiated fraction, the collected charge in the TLD was
read in a regularly calibrated automatic nitrogen flow
Harshaw 5500 reader (Harshaw Chemical Company).
The background dose was estimated by using non-
irradiated TLDs and subtracted from all the TLD
measured values. The following equation was used to
calculate the mean equivalent dose or radiation
weighted dose HT for all organs or tissues T:
HT5WR+
i
fiDTi
where WR is the radiation weighting factor (1 for X-
rays), fi is the irradiated fraction of the tissue T in the
slice i and DTi is the mean absorbed dose of tissue/organ
T in slice i (Table 2).
As described by Golikov and Nikitin,18 each organ in
the phantom, except bone, was a homogeneous soft-
tissue organ, therefore the mass fraction to volume
fraction ratio was 1. The Golikov and Nikitin’s method
was used by Scalzetti et al19 to determine the mass
fraction for the organs at risk.
The salivary glands, thyroid gland, brain, extrathoracic
airways and oral mucosa were entirely within the head
and neck area (100% irradiated fraction), whereas the
oesophagus, skin, lymphatic nodes, muscles, bone
marrow and bone surface were only partially included.
The extrathoracic airways, oral mucosa, lymphatic nodes
and muscles formed part of the remainder tissues. The
head and neck area included 10% of the oesophagus and
5% of the skin, muscles and lymphatic nodes with respect
to the total body amount of these organs.5 In the case of
a 40-year-old patient, 7.6%, 0.8% and 3.9% of the whole
body’s active bone marrow resides in the cranium, man-
dible and cervical spine, respectively.20
The bone surface was calculated as the percentage of
fresh skull, mandible and cervical spine over the total
fresh skeletal mass21 (the mass of cervical vertebrae was
estimated as being 7/34 of total vertebral mass). The tra-
becular component percentage was then subtracted from
the total skeletal mass to obtain the cortical portion.22
The effective dose was determined by the equation:
E5+
i
WTHT
where S represents the sum of the products of the tissue
weighting factors (WT)—established by the International
Commission on Radiological Protection23—and the
absorbed dose within that tissue HT. For instance, the
contribution of the oesophagus to the effective dose, as
well as for the other organs, was calculated by multi-
plying its absorbed dose by the oesophageal irradiated
fraction (0.1); the resulting value was multiplied by the
weight factor of the oesophagus (0.04).
Image quality
Quantitative assessment of image quality was imple-
mented by measuring spatial and contrast resolution,
represented by modulation transfer function (MTF) and
Figure 1 Overview of all fields of view (FOVs). The multislice spiral CT FOVs are represented in the middle of the picture. The corresponded
FOVs used in CBCT are showed on the edge of the picture.
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contrast-to-noise ratio (CNR, contrast resolution), re-
spectively.24 CNR and MTF were considered together
when interpreting the image quality.
Spatial resolution was measured with a CATPHAN®
504 phantom (The Phantom Laboratory), a cylindrical
phantom consisting of five modules enclosed in a 20-cm
plastic housing that is employed for quality assurance of
CT scanners (http://www.phantomlab.com). A hi-res
module containing a point source was scanned for all
MSCT and CBCT protocols. All data sets were expor-
ted in digital imaging and communications in medicine
format and assessed with a customized version of
Table 2 Tissue weighting factors (WT), fractions irradiated (fi) and dosemeters (number and location) used to calculate the effective dose
Organ WT fi Number of TLD Slice
Lens of eye 1–4 4
Right lens of eye 1, 2 4
Left lens of eye 3, 4 4
Ossicles chain 5–8 5
Right ossicles chain 5, 6 5
Left ossicles chain 7, 8 5
Thyroid 0.04 1 9–12 9
Thyroid—right 9, 10 9
Thyroid—left 11, 12 9
Salivary glands 0.01 1 13–22 7, 8
Right submandibular gland 13, 14 8
Left submandibular gland 15, 16 8
Right parotid 17, 18 7
Left parotid 19, 20 7
Centre sublingual gland 21, 22 8
Bone marrow 0.12 0.123 23-28, 33–36, 41-46 2, 3, 6, 7, 8, 9
Calvaria/skull base 0.076 23-28, 45, 46 2, 3, 6
Calvarium anterior 23, 24 2
Calvarium posterior 25, 26 3
Calvarium right 27, 28 3
Skull base 45, 46 6
Mandible 0.008 33–36 8
Mandible right (trabecular) 33, 34 8
Mandible left (trabecular) 35, 36 8
Cervical spine 0.039 41–44 7, 9
Cervical spine C2 (trabecular) 41, 42 7
Cervical spine C4 (trabecular) 43, 44 9
Bone surface 0.01 0.133 23-32, 37-40 2, 3, 7, 8, 9
Calvaria 0.112 23–28 2, 3
Calvarium anterior 23, 24 2
Calvarium posterior 25, 26 3
Calvarium right 27, 28 3
Mandible 0.011 29–32 8
Mandible right (cortical) 29, 30 8
Mandible left (cortical) 31, 32 8
Cervical spine 0.010 37–40 7, 9
Cervical spine C2 (cortical) 37, 38 7
Cervical spine C4 (cortical) 39, 40 9
Brain 0.01 1 47–50 3, 4
Pituitary gland 47, 48 4
Mid-brain 49, 50 3
Oesophagus 0.04 0.1 51, 52 9
Skin 0.01 0.05 53–56 6, 7
Skin—right cheek 53, 54 6
Skin—back of the neck 55, 56 7
Extrathoracic airway 0.0086 1 57–62 4, 5, 7
Oropharyngeal airway 57, 58 7
Right maxillary sinus 59, 60 5
Left ethmoid 61, 62 4
Oral mucosa 0.0086 1 63, 64 6
Lymph nodes 0.0086 0.05 65–68 9
Right laterocervical lymph nodes 65, 66 9
Left laterocervical lymph nodes 67, 68 9
Muscles 0.0086 0.05 69–74 5, 6, 8
Right cutaneous muscles 69, 70 6
Left masticatory muscle 71, 72 5
Back of the neck muscles 73, 74 8
TLD, thermoluminescence dosemeter.
Extrathoracic airways, oral mucosa, lymphatic nodes and muscles form part of the remainder tissues.
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MATLAB® (MathWorks®, Natick, MA; https://www.
mathworks.com/products/matlab.html) to calculate the
MTF. The MTF is given by the Fourier transform of
the point spread function, a delta function which
describes the imaging system response to a point input.
The ideal MTF is independent from the spatial fre-
quency and corresponds to the point spread function. A
broader point spread function corresponds to a nar-
rower MTF and a greater loss of high spatial frequency
information. In the present study, the MTF was eval-
uated at 50% frequency cut-off, since MTF evaluation
at 10% frequency cut-off was unachievable in some
acquisitions.
Owing to the limited size of the FOV, the CNR
evaluation in CBCT required the use of a special
phantom obtained by assembling five tissue substitute
plugs of different certified materials (Gammex RMI®,
Middelton, WI) with electron density relative to water
ranging from 1.018 to 1.82 g cm23. The phantom was
scanned for every CBCT and MSCT protocol, and the
images were processed using ImageJ25 (a public do-
main, Java-based open architecture source code de-
veloped at the National Institutes of Health, https://
imagej.nih.gov/ij). The mean values and standard
deviations for the regions of interest set on each insert
were calculated to evaluate the CNR, according to the
following definition:
CNRi5
Ii2 Iweffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
s2i 1s
2
we
q
where Ii  , si and Iwe, swe represent the mean values and
standard deviations for the insert i and for the water
equivalent one, respectively. The latter had the lowest
contrast with the background.
Results
Dose
The organ dose and effective dose for each anatomical
area are illustrated in Tables 3 and 4.
Multislice spiral CT vs CBCT: The effective dose
measured for CBCT was 7.2%, 13.1%, 54.7%, 69.5%
and 84.7% of the effective dose of MSCT in the cervical
spine, head, ear, dental arches with small FOV and
dental arches with medium FOV, respectively. In CBCT
standard-regular protocol for cervical spine and head
scans, the most significant difference between the two
CT technologies was observed in the thyroid gland. The
CBCT thyroid effective dose was 9.1% and 23.0% of
MSCT thyroid effective dose for the cervical spine and
head scans, respectively. On the contrary, in CBCT
hi-res-enhanced protocols (scans of the ear and dental
arches), some organs showed the same or almost iden-
tical effective dose with respect to MSCT. This is the
case for the skin in scans of the ear and for the re-
mainder tissue in scans of the dental arches.
In CBCT, the highest organ doses were those of the
ossicular chain (19.0 mGy) and salivary glands (12.0
mGy) in scans of the ear and dental arches, respectively.
In MSCT, the highest organ dose affected the thyroid
gland (49.0 mGy) in the cervical spine scan, followed by
the eye lens (42.3 mGy) and ossicular chain (37.7 mGy)
in ear scan.
Cervical spine scan: The thyroid gland contributed the
most to the effective dose (57.5% in MSCT and 71.8%
in CBCT).
Head scan: In MSCT, the thyroid gland, bone marrow
and remainder tissues provided around 21.5% of the
effective dose, each. In CBCT, the thyroid gland
Table 3 Absorbed dose, effective dose and the contribution ðWTHTÞ of the dose of each organ/tissue to the cervical spine and head effective doses
Tissue/organ
Cervical spine Head
Absorbed
dose (mGy) WTHT (mSv, %)
Absorbed
dose (mGy) WTHT (mSv, %)
MS CB MS CB CB/MS MS CB MS CB CB/MS
Lens of eye 27.3 1.1 30.8 4.2
Ossicles chain 19.1 0.1 28.1 3.1
Thyroid gland 49.0 4.4 1960 (57.5%) 178 (71.8%) 9.1% 10.0 2.3 400 (21.1%) 92 (36.7%) 23.0%
Salivary glands 32.0 2.5 320 (9.4%) 26 (10.5%) 8.1% 30.7 3.6 307 (16.2%) 36 (14.5%) 11.7%
Bone marrow 4.0 0.2 488 (14.3%) 29 (11.7%) 5.9% 3.4 0.3 409 (21.6%) 41 (16.5%) 10.0%
Bone surface 3.4 0.2 34 (1.0%) 3 (1.2%) 8.8% 2.8 0.3 28 (1.5%) 3 (1.2%) 10.7%
Brain 9.0 0.1 90 (2.6%) 1 (0.4%) 1.1% 22.7 1.2 228 (12.0%) 13 (5.2%) 5.7%
Oesophagus 2.9 0.1 116 (3.4%) 3 (1.2%) 2.6% 2.3 0.2 93 (4.9%) 11 (4.4%) 11.8%
Skin 1.3 0.1 13 (0.4%) 1 (0.4%) 7.6% 1.2 0.1 13 (0.7%) 2 (0.8%) 12.0%
RT EA 22.3 0.4 192 (5.7%) 3 (1.2%) 1.5% 20.5 3.1 177 (9.4%) 27 (10.8%) 15.3%
Oral mucosa 20.0 0.2 172 (5.1%) 2 (0.8%) 1.1% 24.5 2.4 211 (11.2%) 21 (8.4%) 9.9%
Lymph nodes 1.4 0.1 12 (0.3%) 1 (0.4%) 8.3% 1.6 0.2 14 (0.7%) 2 (0.8%) 14.2%
Muscles 1.4 0.1 12 (0.3%) 1 (0.4%) 8.3% 1.4 0.2 12 (0.6%) 1 (0.4%) 8.3%
Total 45.1 0.8 388 (11.4%) 7 (2.8%) 1.8% 48.0 5.9 414 (21.9%) 51 (20.5%) 12.3%
Effective dose [mSv] — — 3409 (100%) 248 (100%) 7.2% — — 1892 (100%) 249 (100%) 13.1%
CB, CBCT; EA, extrathoracic airways; HT, equivalent dose; MS, multislice CT; RT, remainder tissues; WT, tissue weighting factor.
The value of absorbed dose of each organ is already multiplied by its irradiated fraction. All values of the effective dose are approximate.
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contributed the most to the effective dose with 36.7%,
followed by the remainder tissues and bone marrow
with 20.5% and 16.5%, respectively.
Ear scan: The dominant contributions to the effective
dose originated from the bone marrow, salivary glands
and remainder tissues. They were 28.3%, 20.3% and
18.2% in MSCT; 26.6%, 27.1% and 23.3% in CBCT,
respectively.
In addition, the contributing percentage of the brain
to the effective dose in ear and head MSCT scans was
around twice that of CBCT (15.8% vs 8.6% and 12.0%
vs 5.2%, respectively).
Dental arches scan: The most significant contributions
to the effective dose derived from the thyroid gland
and remainder tissues (around 25% in MSCT and 30%
in CBCT), followed by the bone marrow and salivary
glands (17.5% in both MSCT and CBCT).
Image quality
The MTF of CBCT was 0.895, 0.895, 0.875 and 0.961
in the cervical spine, head, ear and dental arches, re-
spectively. The MTF of MSCT was 0.347, 0.275, 0.342
and 0.352 in the cervical spine, head, ear and dental
arches, respectively. In Figure 2, 50% cut-offs of the
MTFs were reported. The 50% MTF ratios between
CBCT and MSCT were 2.6 (cervical spine and ear),
2.7 (dental arches) and 3.3 (head). This demonstrated
that CBCT images had better spatial resolution than
MSCT for all protocols.
The CNR values, as function of the plugs density,
were reported in Figures 3 and 4. At densities around
1 g cm23 (solid water and brain), the CNR showed
similar values in MSCT and CBCT whilst at higher
densities—i.e. between 1 and 2 (inner and cortical
bone)—head and cervical spine MSCT showed pro-
gressively greater CNR than CBCT. The CNR values
were comparable in all the other protocols, even
though CBCT showed slightly better values
than MSCT.
When MTF and CNR values were considered to-
gether, CBCT image quality was higher than MSCT
for scans of the ear and dental arches, whereas for head
and cervical spine scans, a definite judgment on which
CT-technologies had the highest image quality was not
possible.
Discussion
In scans of the dental arches, CBCT showed effective
dose somewhat below (around three-quarters) and
image quality greater for its obvious higher spatial
resolution than low-dose Dentascan-MSCT. The same
considerations can be applied to the ear study in which
the effective dose of CBCT was about half that of
MSCT, but the image quality of CBCT was greaterTa
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thanks to its superior spatial resolution with similar
contrast resolution.
In head and cervical spine scans, the effective dose of
CBCT was evidently lower (around one-tenth) than
MSCT. CBCT showed superior spatial resolution
(MTF) but inferior CNR than MSCT. It is not possible
to assess the individual contribution of MTF and CNR
to the overall image quality, therefore which CT tech-
nology has the highest image quality remains unclear in
this case. Since the current article focused on the tech-
nical quality of the image, it is also worth emphasising
that technical and clinical image quality do not always
correlate.
In general terms, CBCT has greater spatial resolution
than MSCT because it uses flat-panel detectors with
thinner scintillator layers and smaller pixels than those
of MSCT. Unlike MSCT, in CBCT there is no post-
patient collimation. As a result, the image is obtained
with fewer photons being wasted, although its quality is
degraded by scattered radiation. Both these techniques
use the same image reconstruction principle, termed
back-projection, with the addition of Feldkamp’s algo-
rithm in CBCT.26 MSCT is characterized by greater
mA and wider dynamic range. For all the above rea-
sons, MSCT has greater contrast and temporal resolu-
tion than CBCT.27
Additional differences shall be taken into account for
a fair comparison between CBCT and MSCT. The
latter is widespread in all developed countries and so
more easily accessible, allows a better image quality for
soft tissue visualization and can also be used for
contrast-enhanced examinations. Conversely, CBCT is
typically used for any type of dental and jaw disorders,
except for neoplastic lesions where the administration of
contrast agents and the assessment of the soft tissues are
mandatory. The same observations can be applied to
the ear and cervical studies, where MSCT is un-
doubtedly preferable to CBCT if a malignant lesion
Figure 2 Multislice spiral CT (MSCT) and CBCT values in correspondence of the modulation transfer function (MTF) 50% cut-off for each
anatomical area.
Figure 3 Multislice spiral CT (MSCT) contrast-to-noise (CNR) values as a function of the plugs density for each anatomical area.
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involving the skull base or the vertebral canal is sus-
pected. When the head scan is carried out for orthog-
nathodontic purposes, CBCT is recommended, but in
the case of trauma and/or inflammation/neoplastic
lesions, MSCT is mandatory.15
CBCT comes at lower mean technical and operating
costs per procedure, approximately €60 and €150 for
CBCT and unenhanced MSCT, respectively.28,29 A
disadvantage of CBCT is represented by its long scan
time. This facilitates the presence of motion artefacts30
and can negatively affect both the technical and clinical
quality of the image compared with MSCT.
With two efficient CT techniques available for head
and neck imaging, clinicians and radiologists must
carefully evaluate—depending on the clinical query and
anatomical structures under examination—whether to
favour the reduction of radiation dose at the detriment
of image quality, or better image quality at the cost of
higher radiation dose. Finding a balance between ben-
efit and potential harm to the patient is a critical point
in the field of radiology.
The concept of irradiated fraction has long been de-
bated. In our study, it does not represent the portion of
a certain organ included in a specific FOV, but the
percentage of the organ included in the head and neck
area with respect to the total body amount of that same
organ. Consequently, the irradiated fraction was 100%
for salivary glands, thyroid gland, brain, extrathoracic
airways and oral mucosa, whereas it was 13.3% for
bone surface, 12.3% for bone marrow, 10% for oe-
sophagus and 5% for skin, muscles and lymphatic
nodes.5,20–22 In case a different approach is used, the
various organ irradiated fractions may vary, therefore
the relative dosimetric values will not be comparable.
Organs and tissues receiving the highest organ dose
were those located inside the primary beam and studied
with high tube current–exposure time products. They
were the thyroid gland in cervical spine scan and the eye
lens, ossicular chain and muscles in ear scan.
In head scans, the dose to the thyroid gland—in
comparison to the overall effective dose—showed
a percentage value clearly higher in CBCT than MSCT
(36.7% vs 21.1%). This is because in CBCT, the head
scan is performed for orthodontic purposes, and all the
soft tissues of the face must be included within the FOV.
Therefore in CBCT, at least part of the thyroid gland is
directly exposed to the primary beam, whereas in
MSCT, it completely sits below the field of direct ex-
posure. Consequently, the caudal positioning of the
FOV becomes a critical point. Slight downward move-
ment or rotation of the Frankfort plane31,32 can lead to
a significant increase of the dose to the thyroid, with an
obvious increase of the effective dose. To reduce the
patient’s radiation dose in the case of CBCT with large
FOV, the head should be slightly extended as to avoid
the thyroid gland being affected by the primary beam.
This does not jeopardize the correct execution of the
examination since CBCT uses isotropic voxels, thus the
volumetric data set can be oriented at any plane desired
during the reconstruction process.33
In head and ear scans performed with MSCT, the
dose percentage to the brain was twice that of CBCT.
That was because in the MSCT head scan, the cranial
positioning of the FOV affected the entire head,
whereas it just barely included the frontal sinus in
CBCT. In the ear scan, it was because the FOV of the
MSCT was cranially 1 cm larger than the FOV of
CBCT (6 vs 5 cm), including the pituitary gland in the
radiation field. In the current study, bone marrow,
salivary glands and remainder tissues were pre-
dominantly responsible for the effective dose in CBCT
and MSCT ear scans. Zou et al14 reported lower dose
values for the salivary glands and remainder tissues in
CBCT ear scan due to the use of a different CBCT unit
with a smaller FOV (63 6 cm) that included mainly the
brain in the primary beam, as well as the bone marrow.
In cervical scans, the thyroid gland was responsible
for most of the effective dose (57.5% in MSCT and
Figure 4 CBCT contrast-to-noise (CNR) values as a function of the plugs density for each anatomical area.
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71.8% in CBCT) because it was the only one highly
radiation-sensitive organ (weight factor 0.04) with high
irradiated fraction (100%) included in the primary
beam. The lower thyroid dose percentage in MSCT
depended on the bigger craniocaudal diameter of the
FOV (18 vs 16 cm), producing higher dose to the brain,
oesophagus and extrathoracic airway.
In dental arches scans, as reported in other studies,5 the
salivary glands (especially the parotid) were the organs
mostly exposed to radiation because they were directly
irradiated by the central X-ray beam. Nevertheless, the
organs contributing to the most part of the effective dose
were the thyroid glands due to a higher weight factor and
irradiated fraction, and the remainder tissues due to the
sum of the dose of four organs (extrathoracic airways,
oral mucosa, lymphatic nodes, and muscles).
The only previous article estimating the effective dose
in the head and neck area with NewTom5G CBCT was
published by Dierckx et al.13 They analyzed the ear
using identical technical/geometrical CBCT parameters
adopted in the current study, nevertheless MSCT de-
livered an effective dose six times higher than CBCT
(and not twice as in our case). This is because of the
marked difference in parameters between the two
MSCT units, in particular 300 mAs and 140 kV vs 120
mAs and 120 kV in the current study.
When comparing the effective dose of NewTom5G
and different CBCT units with similar FOVs,9
NewTom5G fell within the middle range in head scan
(249 mSv in the current study vs 46–498 mSv) and over
the range in dental scan (565 mSv with small FOV and
688 mSv with medium FOV vs 69–453 mSv) due to dif-
ferent technical/geometrical parameters and hardware
between the CBCT units.
Such major differences in patient dose highlight the
importance of knowledge and optimization of the
parameters during CBCT examinations. This reflects on
image resolution because dose reduction leads to re-
duction in image quality.
The main limit of this study was that no repeated
measurements were carried out since the use of a large
number of TLDs, although improving the accuracy of
dose calculation is a time consuming process. However
in our series, the dosimetric values were given by the
mean value of two measurements (a couple of dose-
meters in each hole) performed during the same
session.
Another weakness in our study was the use of CNR
metric to compare protocols and scanners with different
voxel sizes: smaller voxels do not receive as many
photons as larger voxels, resulting in an intrinsic re-
duction of signal that leads to an increase in noise.
Finally, the effective dose of each anatomical area
was compared with the radiation exposure resulting
from common everyday occurrences and different di-
agnostic procedures; it is indeed interesting to notice
significant dosimetric differences among the different
scans (Tables 3 and 4) and their possible con-
sequences (Table 5).
In conclusion, even though the current study was
carried out on phantoms and thus the results could be
slightly different in a clinical setting, it can be
stated that:
(i) In the ear and dental arches imaging, CBCT was
preferable to MSCT due to its lower radiation dose
and significantly higher spatial resolution;
(ii) In the cervical spine and head imaging, the choice
between CBCT and MSCT should depend on the
clinical query. MSCT should be recommended when
a high contrast resolution is required, despite the
greater radiation exposure.
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